Samuraciclib improved progression-free survival in HR+ advanced breast cancer patients without TP53 mutations or liver ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung ...

Ariel Lopez-Chavez, MD, medical oncologist, director of precision medicine and developmental therapeutics at Allegheny Health Network Cancer Institute, discusses comprehensive genomic profiling and ...

The FDA granted accelerated approval to telisotuzumab vedotin (Emrelis) for the treatment of adults with previously treated, ...

Scientists have discovered how iron in lysosomes can induce ferroptosis, offering a new route to target treatment-resistant ...

Some 50,000 Australians will die from cancer this year, despite big breakthroughs in treatments. What makes cancer so very ...